Who owns FULC?
Institutional ownership of Fulcrum Therapeutics Inc. from Form 13F, Q2 2026
155 institutional managers reported holding Fulcrum Therapeutics Inc. (FULC) in Form 13F filings for Q2 2026, with 85,804,826 shares worth $314M. The largest reported holder was Nantahala Capital Management, LLC. Managers that filed both quarters added a net 14,099,788 shares (+19.7%). 29 opened new positions and 42 sold out.
- Funds holding
- 155
- Value held
- $314M
- New / sold out
- 29 / 42
- Net shares, same filers
- +19.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of FULC
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $40.1M | 12.8% | 10,950,080 | Added |
| BlackRock, Inc. | $32.3M | 10.3% | 8,824,259 | Added |
| EcoR1 Capital, LLC | $24.0M | 7.6% | 6,549,866 | New |
| Tang Capital Management LLC | $23.9M | 7.6% | 6,521,412 | New |
| Montanova Capital, LLC | $13.5M | 4.3% | 3,680,921 | Trimmed |
| D. E. Shaw & Co., Inc. | $11.1M | 3.5% | 3,044,385 | Added |
| Citadel Advisors LLC | $9.9M | 3.2% | 2,704,505 | Added |
| Vanguard Capital Management LLC | $9.9M | 3.1% | 2,697,216 | Added |
| Jane Street Group, LLC | $8.1M | 2.6% | 2,217,498 | Added |
| State Street Corp | $7.5M | 2.4% | 2,037,025 | Added |
| Adage Capital Partners GP, L.l.c. | $7.3M | 2.3% | 2,000,000 | Added |
| GSK plc | $6.5M | 2.1% | 1,785,714 | Unchanged |
| Qube Research & Technologies Ltd | $6.4M | 2.0% | 1,748,467 | Added |
| Assenagon Asset Management S.A. | $6.1M | 1.9% | 1,670,408 | Added |
| Renaissance Technologies LLC | $6.0M | 1.9% | 1,647,800 | Added |
| ADAR1 Capital Management, LLC | $5.7M | 1.8% | 1,565,029 | Added |
| Millennium Management LLC | $5.4M | 1.7% | 1,485,803 | Added |
| Geode Capital Management, LLC | $5.2M | 1.7% | 1,432,133 | Trimmed |
| Marshall Wace, LLP | $5.0M | 1.6% | 1,358,423 | New |
| UBS Group AG | $4.6M | 1.5% | 1,253,909 | Added |
| Susquehanna International Group, LLP | $4.3M | 1.4% | 1,180,946 | Added |
| AQR Capital Management LLC | $4.0M | 1.3% | 1,103,261 | Added |
| Goldman Sachs Group Inc | $4.0M | 1.3% | 1,094,425 | Added |
| Ikarian Capital, LLC | $3.8M | 1.2% | 1,049,161 | Unchanged |
| Bank of America Corp | $3.8M | 1.2% | 1,043,029 | Added |
Share of 13F holdings is each fund's shares as a share of the 85,804,826 FULC shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Nantahala Capital Management, LLC Added+$28.9M
- EcoR1 Capital, LLC New+$24.0M
- Tang Capital Management LLC New+$23.9M
- BlackRock, Inc. Added+$12.6M
- Jane Street Group, LLC Added+$7.0M
- Renaissance Technologies LLC Added+$6.0M
- Adage Capital Partners GP, L.l.c. Added+$5.9M
- ADAR1 Capital Management, LLC Added+$5.3M
- D. E. Shaw & Co., Inc. Added+$5.2M
- Citadel Advisors LLC Added+$5.2M
Biggest sellers in Q2 2026
- Ra Capital Management, L.p. Sold out-$46.4M
- TCG Crossover Management, LLC Sold out-$40.3M
- Braidwell LP Sold out-$24.0M
- Siren, L.L.C. Sold out-$18.0M
- First Turn Management, LLC Sold out-$17.3M
- Aberdeen Group plc Sold out-$17.0M
- Jones Hill Capital LP Sold out-$13.6M
- Montanova Capital, LLC Trimmed-$10.5M
- Alyeska Investment Group, L.P. Sold out-$10.2M
- Vestal Point Capital, LP Sold out-$8.4M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $174M and sold $231M; 73 added and 33 trimmed.
Schedule 13D and 13G filings on FULC
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-14Nantahala Capital Management, LLC SCHEDULE 13G filed by Fulcrum Therapeutics Inc.Schedule 13G
- 2026-08-03BANK OF AMERICA CORP /DE/ SCHEDULE 13G filed by Fulcrum Therapeutics Inc.Schedule 13G
- 2026-06-25EcoR1 Capital, LLC SCHEDULE 13G filed by Fulcrum Therapeutics Inc.Schedule 13G
- 2026-06-25EcoR1 Capital, LLC SCHEDULE 13G filed by Fulcrum Therapeutics Inc.Schedule 13G
- 2026-06-10TANG CAPITAL MANAGEMENT LLC SCHEDULE 13G filed by Fulcrum Therapeutics Inc.Schedule 13G
- 2025-02-12Adage Capital Management, L.P. SCHEDULE 13G filed by Fulcrum Therapeutics Inc.Schedule 13G
- 2025-01-06SUVRETTA CAPITAL MANAGEMENT, LLC SCHEDULE 13G filed by Fulcrum Therapeutics Inc.Schedule 13G
Questions about FULC ownership
- Who owns FULC stock?
- 155 institutional investment managers reported FULC positions in their Form 13F filings for Q2 2026, holding 85,804,826 shares worth $314M in total. Nantahala Capital Management, LLC reported the largest position.
- Are funds buying or selling FULC?
- In Q2 2026, 29 managers opened new FULC positions, 73 added, 33 trimmed and 42 sold out. Managers that filed in both quarters added a net 14,099,788 shares.
- How current is this FULC institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to FULC by CUSIP. Options are left out. FULC news and filings · FULC insider trades · Top funds